Meta-analysis of epigenome-wide associations between DNA methylation at birth and childhood cognitive skills
- PMID: 35145228
- PMCID: PMC9126809
- DOI: 10.1038/s41380-022-01441-w
Meta-analysis of epigenome-wide associations between DNA methylation at birth and childhood cognitive skills
Abstract
Cognitive skills are a strong predictor of a wide range of later life outcomes. Genetic and epigenetic associations across the genome explain some of the variation in general cognitive abilities in the general population and it is plausible that epigenetic associations might arise from prenatal environmental exposures and/or genetic variation early in life. We investigated the association between cord blood DNA methylation at birth and cognitive skills assessed in children from eight pregnancy cohorts within the Pregnancy And Childhood Epigenetics (PACE) Consortium across overall (total N = 2196), verbal (total N = 2206) and non-verbal cognitive scores (total N = 3300). The associations at single CpG sites were weak for all of the cognitive domains investigated. One region near DUSP22 on chromosome 6 was associated with non-verbal cognition in a model adjusted for maternal IQ. We conclude that there is little evidence to support the idea that variation in cord blood DNA methylation at single CpG sites is associated with cognitive skills and further studies are needed to confirm the association at DUSP22.
© 2022. The Author(s).
Conflict of interest statement
MD served as PI in phase II and III studies of Johnson & Johnson, Lilly and Roche. He participated in advisory boards of Johnson & Johnson and received speaker fees from Mundipharma. GT received a Student/New Investigator Travel Award of $750.00 to attend and present at the 2019 Environmental Mutagenesis and Genomics Society (EMGS) meeting in Washington DC from September 19–23, 2019. All the other co-authors declare no competing interests.
Figures
References
Publication types
MeSH terms
Grants and funding
- R24 ES028529/ES/NIEHS NIH HHS/United States
- R01 ES031259/ES/NIEHS NIH HHS/United States
- 217065/Z/19/Z/WT_/Wellcome Trust/United Kingdom
- R01 DA035300/DA/NIDA NIH HHS/United States
- R01 ES023067/ES/NIEHS NIH HHS/United States
- R01 HD034568/HD/NICHD NIH HHS/United States
- UH3 OD023286/OD/NIH HHS/United States
- MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom
- R01 HD068437/HD/NICHD NIH HHS/United States
- UG3 OD023356/OD/NIH HHS/United States
- MC_UU_00011/6/MRC_/Medical Research Council/United Kingdom
- P01 ES009605/ES/NIEHS NIH HHS/United States
- MR/S036520/1/MRC_/Medical Research Council/United Kingdom
- BBI025751/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- CIHR/Canada
- T32 MH112510/MH/NIMH NIH HHS/United States
- R01 ES021369/ES/NIEHS NIH HHS/United States
- MC_UU_00011/5/MRC_/Medical Research Council/United Kingdom
- F31 ES027751/ES/NIEHS NIH HHS/United States
- BB/I025263/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- MR/S009310/1/MRC_/Medical Research Council/United Kingdom
